Status: Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Participants needed: 120
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: SystImmune Inc.Updated: May 22, 2026Locations: 20
Eligibility criteria
Documented locally advanced or metastatic SCLC, large cell neuroendocrine cancer... [+8]
Chemotherapy, biological therapy, immunotherapy, , targeted therapy (including s... [+7]